User profiles for Calvin H. Yeh
 | Calvin YehUniversity of Toronto Verified email at medportal.ca Cited by 1825 |
Overview of the new oral anticoagulants: opportunities and challenges
The non-vitamin K antagonist oral anticoagulants (NOACs) are replacing warfarin for many
indications. These agents include dabigatran, which inhibits thrombin, and rivaroxaban, …
indications. These agents include dabigatran, which inhibits thrombin, and rivaroxaban, …
Evolving use of new oral anticoagulants for treatment of venous thromboembolism
The new oral anticoagulants (NOACs), which include dabigatran, rivaroxaban, apixaban,
and edoxaban, are poised to replace warfarin for treatment of the majority of patients with …
and edoxaban, are poised to replace warfarin for treatment of the majority of patients with …
Oral direct factor Xa inhibitors
Vitamin K antagonists, such as warfarin, have been the mainstay of oral anticoagulation for
many decades. Although effective, warfarin has numerous limitations, including a variable …
many decades. Although effective, warfarin has numerous limitations, including a variable …
The impact of social media promotion with infographics and podcasts on research dissemination and readership
ObjectiveIn 2015 and 2016, the Canadian Journal of Emergency Medicine (CJEM) Social
Media (SoMe) Team collaborated with established medical websites to promote CJEM articles …
Media (SoMe) Team collaborated with established medical websites to promote CJEM articles …
[HTML][HTML] Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: a single‐center prospective longitudinal study
Background Immunothrombosis and coagulopathy in the lung microvasculature may lead to
lung injury and disease progression in coronavirus disease 2019 (COVID‐19). We aim to …
lung injury and disease progression in coronavirus disease 2019 (COVID‐19). We aim to …
Defining trauma‐induced coagulopathy with respect to future implications for patient management: communication from the SSC of the ISTH
Trauma-induced coagulopathy (TIC) is a clinical scenario spanning the spectrum of
hypocoagulability to hypercoagulability causing a wide range of complications including …
hypocoagulability to hypercoagulability causing a wide range of complications including …
The effect of an infographic promotion on research dissemination and readership: a randomized controlled trial
ObjectiveJournals use social media to increase the awareness of their publications.
Infographics show research findings in a concise and visually appealing manner, well suited for …
Infographics show research findings in a concise and visually appealing manner, well suited for …
A regional massive hemorrhage protocol developed through a modified Delphi technique
Background: A massive hemorrhage protocol (MHP) enables rapid delivery of blood components
in a patient who is exsanguinating pending definitive hemorrhage control, but there is …
in a patient who is exsanguinating pending definitive hemorrhage control, but there is …
[HTML][HTML] Immunothrombosis biomarkers for distinguishing coronavirus disease 2019 patients from noncoronavirus disease septic patients with pneumonia and for …
OBJECTIVES: In this pilot observational study, we investigated the utility of immunothrombosis
biomarkers for distinguishing between coronavirus disease 2019 patients and …
biomarkers for distinguishing between coronavirus disease 2019 patients and …
[HTML][HTML] Mechanistic basis for the differential effects of rivaroxaban and apixaban on global tests of coagulation
Rivaroxaban and apixaban are both small molecules that reversibly inhibit factor Xa. Compared
with rivaroxaban, apixaban has minimal effects on the prothrombin time and activated …
with rivaroxaban, apixaban has minimal effects on the prothrombin time and activated …